BioSpecifics appoints board members
This article was originally published in Scrip
Executive Summary
Lynbrook, New York-based BioSpecifics Technologies, a biopharmaceutical company developing first-in-class collagenase-based products, has named two new members to its board of directors: Jennifer Chao and Dr Jyrki Mattila. Ms Chao is an advisory analyst at CoreStrategies Management, a strategic consulting firm she founded in 2008 focused on providing transformational strategy and maximizing corporate valuation. Meanwhile, Dr Mattila is chief business officer of iCeutica. Prior to joining iCeutica in 2013, Dr Mattila was president and CEO of LZ Therapeutics.